Take Advantage of OA Benefits

FinELib license agreements for scholarly journals include open access benefits. They enable the corresponding authors to publish their articles openly, either free of article processing charges or with a discounted price.

Terms under which the benefits are available and the processes of the publishers vary.

The benefits agreed are listed below. More information is available from your own library or information service.

OA2

Instructions to the Corresponding Author

American Chemical Society (ACS)

FinELib consortium’s agreement with ACS offers authors an opportunity to publish their articles open access during the agreement term 2021 – 2023 without article processing charges (APC).

Elsevier

Under FinELib consortium’s agreement with Elsevier, authors can publish their articles open access without article processing charge (APC) in Elsevier hybrid journals eligible for the agreement.

Emerald

FinELib consortium’s agreement with Emerald offers authors an opportunity to publish their articles under the CC BY-license with a free open access voucher.

This means that there is no article processing charge for the author.

IEEE

FinELib consortium’s agreement with IEEE offers the opportunity to publish articles open access without an article processing charge in IEEE:s hybrid and fully open access journals.

Oxford University Press

The agreement allows authors to publish their research open access in OUP’s hybrid journals at no additional charge.

Royal Society of Chemistry (RSC)

Researchers can publish their articles open access in RSC hybrid journals without additional payment, since the costs have been covered as a part of FinELib consortium’s agreement.

SAGE

Researchers can publish their articles open access without additional payment in SAGE hybrid journals or get a 20% discount on APC’s when publishing in SAGE Full OA journals, since the costs are covered as part of the FinELib consortium’s agreement.

Science Advances Journal

Researchers get a 15% discount of the APC fee of Science Advances -journal. Science Advances is an online-only open access journal.

Springer Nature

FinELib consortium’s agreement with Springer Nature includes open access publishing in Springer’s hybrid titles without article processing charge (APC).

Taylor & Francis

The agreement between FinELib and Taylor & Francis gives the researchers of the subscribing member organizations an opportunity to publish a limited amount of articles open access without additional payment in the Taylor & Francis Open Select standard rate journals and in the Open Access journal Annals of Medicine.

Wiley

FinELib consortium’s agreement with Wiley enables the researchers to publish their articles open access in Wiley’s Full OA and hybrid journals without additional payment.

Wolters Kluwer / Lippincott (LWW)

FinELib consortium’s agreement with Wolters Kluwer Health offers authors an opportunity to publish their articles under the CC BY or CC BY-NC-ND license with a free open access.

This means that there is no article processing charge for the author.

Read more about the negotiations
Read more about our goals

Take advantage of
open access benefits

During negotiations, open access benefits have been agreed upon regarding the journals of the following publishers:
American Chemical Society  |  Elsevier  |  Emerald |  IEEE  |  Oxford University Press  |  Royal Society of Chemistry  |  Sage  |  Science Advances  |  Springer Nature  |  Taylor & Francis  |  Wiley |  Wolters Kluwer/Lippincott

More information about publisher- and organisation-specific open access benefits is also available from your own library.